Catalogue Number: A4031-APE
Manufacturer: | Apexbio |
Molecular Formula: | C36H53N7O6 |
Physical state: | A solid |
Type: | Protease Inhibitors |
Alias: | VX950, VX 950, MP-424,Telaprevir |
Shipping Condition: | Blue Ice |
Unit(s): | 10 mg, 10 mM (in 1mL DMSO), 2 mg, 25 mg, 5 mg |
Description: Telaprevir (also known as VX-950), derived from the viral NS5A/5B substrate of the protease through structure-based techniques, is a novel and potent inhibitor of hepatitis C virus (HCV) NS3-4A protease, which covalently and reversibly inhibit the NS3-4A protease via a slow-binding and slow-dissociation mechanism. Results of multiple studies show that telaprevir potently inhibits a genotype 1 (H strain) NS3 protease domain plus a NS4A cofactor peptide with the inhibitory constant (Ki) of 7 nM, exhibits strong anti-HCV in HCV replicon cells in vitro, and suppresses HCV replication as well as the emergence of resistance in HCV replicon cells with a synergistic effect with IFN-α.ReferenceKai Lin, Robert B. Perni, Ann D. Kwong, and Chao Lin. VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2006; 50(5): 1813-1822
Store at -20°C
HCV NS3-4A protease inhibitor
CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5
≥32.95 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O